WELCOME TO
Hydra ENT
An Advanced Medical Device Company
Our Technology
SPARx is a first-in-class sinuplasty platform that combines electricity with an FDA approved drug. This product will revolutionize medicine by offering minimal dosage with maximum relief. While carrying less drug, SPARx takes only seconds to securely place a precise amount of drug into it's target tissue. The result is more localized drug in the tissue and less drug everywhere else which means no side effects.
Making Mometasone Furoate (MF, the active drug in Nasonex) last up to 30 days from one maximum dose!
Imagine going to one short visit with your doctor, and leaving free of sinus issues, prescriptions or maintenance protocols.
SinuSPARx, is an FDA approval away from giving you relief. Our preclinical data shows that from a one-day dose equivalent of Nasonex, inflammation is suppressed for 30-40 days. That's 30x less MF for you to put in you body over a 30 day period! Your pancreas, liver, and kidneys will thank you for the SinuSPARx treatment.
Investment opportunity
VALUTATION: $22.5M Post Money
Seed Round: $5M
-
$3M Committed/Closed
-
$2M Available
Convertible Notes:
-
Please contact us for details
